Psoriatic Arthritis

ATLANTA — Fatigue and gastrointestinal complaints were the most common patient-reported adverse events associated with methotrexate among individuals with rheumatoid arthritis and psoriatic arthritis, according to a speaker at ACR/ARP 2019.

ATLANTA — Guselkumab, administered either every 4 or 8 weeks, is efficacious for joint and skin symptoms, as well as physical function and quality of life, among patients with active psoriatic arthritis who are biologic-naive or previously received TNF inhibitors, according to data presented at ACR/ARP 2019.

Most physicians tend to be skeptical of fad health trends. Goat yoga and appetite suppressant lollipops are shockingly — shockingly — popular in certain social media circles, but whether they actually work toward the desired end is another matter altogether.

Secukinumab is beneficial for patients with psoriatic arthritis across the spectrum of clinical phenotypes for the disease, according to findings published in the Journal of Rheumatology.

Since 2004, World Psoriasis Day has been celebrated on Oct. 29.

Ixekizumab is superior to adalimumab in simultaneously improving both joint and skin disease in patients with psoriatic arthritis who have had an inadequate response to conventional synthetic DMARDs, according to data published in the Annals of the Rheumatic Diseases.

The majority of physical therapists can accurately distinguish between inflammatory and noninflammatory arthritis and understand the importance of correct and prompt referrals to a rheumatologist for suspected inflammatory conditions, according to survey results published in Arthritis Care & Research.

Patients with psoriatic arthritis showed long-term efficacy and safety with Cimzia by achieving Disease Activity Index for Psoriatic Arthritis minimal disease activity and very low disease activity in the 4-year RAPID-PsA phase 3 trial, according to results presented at the European Academy of Dermatology and Venereology Congress.

Researchers discovered differences in clinical support and patient education among women of childbearing age with chronic rheumatic diseases in Asia-Pacific and Europe, from a study presented at European League Against Rheumatism.

SAN DIEGO — Contrary to previous findings, the risk for psoriatic arthritis was persistent among patients with psoriasis and did not wane over time, according to a presentation at the 2019 Congress of Clinical Rheumatology West.